Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cingulate Inc (NQ: CING )

4.650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cingulate Inc

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Tumbles 2%; Timber Pharmaceuticals Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 450 points on Friday. The Dow traded down 1.39% to 32,692.94 while the NASDAQ fell 2.14% to 11,342.36. The S&P 500 also... 
Via Benzinga
Why Is Nektar Therapeutics (NKTR) Stock Down 39% Today?
Nektar Therapeutics (NKTR) stock is taking a beating on Friday following the release of poor Phase 2 clinical trial data. 
Via InvestorPlace
Why Is SELLAS Life Sciences (SLS) Stock Down 38% Today?
SELLAS Life Sciences (SLS) stock is falling on Friday after the biopharmaceutical company announced a proposed public offering. 
Via InvestorPlace
Why Cingulate Shares Are Trading Higher Today
Via Benzinga
Meet The Company Creating Novel Products For The Treatment Of ADHD
Sign up for this week’s All Access giveaway here!  Shane Schaffer, CEO of Cingulate, Inc. (NASDAQ: CING), was a guest on Benzinga’s All Access on August 22, 2022. 
Via Benzinga
Why Is Bridger Aerospace (BAER) Stock Up 84% Today?
Bridger Aerospace (BAER) stock is taking off on Friday after a filing revealed an over 22% stake in the company from a group of investors. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Beyond Meat Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers Cingulate Inc (NASDAQ: CING) rose 85.7% to $2.08 in pre-market trading after the company disclosed top-line results from Fed/Fast study of lead asset CTx-1301 for ADHD. 
Via Benzinga
Why Is Cingulate (CING) Stock Up 72% Today?
Cingulate (CING) stock is on the rise Friday after releasing positive data concerning its ADHD treatment, which is in a Phase 3 trial. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start off trading on Friday with a breakdown of the biggest pre-market stock movers worth keeping an eye on! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Cingulate Kickstarts Pivotal Trial For ADHD Candidate, Data Expected In First Half 2023
Cingulate Inc (NASDAQ: CING) has initiated the first Phase 3 clinical trial of its lead candidate CTx-1301, an extended-release tablet formulation of dexmethylphenidate, a compound approved by the FDA... 
Via Benzinga
Over $5 Million Bet On Exicure? Check Out These 4 Penny Stocks Insiders Are Buying
Wall Street closed lower for the fourth straight session on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Cingulate: This Company Is Changing The Way Critical ADHD And Anxiety Meds Are Delivered
Shane Schaffer, Chairman & CEO of Cingulate, Inc. (NASDAQ: CING), was a guest on Benzinga’s All Access on 12/16/22. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
Via Benzinga
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 34 companies set new 52-week lows. 
Via Benzinga
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. 
Via Benzinga
Cingulate Shares Fall After Timeline Update For Its Lead Candidate In ADHD
Cingulate Inc (NASDAQ: CING) is preparing to initiate a Phase 3 adult dose-optimization study later this year for its lead candidate, CTx-1301, to assess the onset and duration of efficacy and safety... 
Via Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
What Is Precision Timed Release (PTR) Technology? A New Way To Treat ADHD
Shane J. Schaffer and Dr. Ann Childress, CEO and consultant at Cingulate Inc. (NASDAQ: CING), respectively, were guest speakers at Benzinga’s All Access on June 3rd, 2022. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.